News | News By Subject | News by Disease News By Date | Search News

Onychomycosis News Articles

Get Our FREE
Industry eNewsletter
email:    
Top Breaking News
Analyst: Current Crop of Biotech IPOs a Mixed Bag of Low Market Caps, Little Data     12/3/2014
Best Value In Biotech? Actavis (ACT), Says UBS     11/17/2014
FDA Approves Valeant Pharmaceuticals International (VRX) Toenail Fungus Drug Jublia®     6/9/2014
Valeant Pharmaceuticals International (VRX) Announces Successful Results From Phase III Onychomycosis Trials     12/16/2011
NexMed (NEXM) Says It Will Not File NDA for Nail Drug     8/27/2008
Arpida Reports Progress in Pivotal Phase III Trial With TLT Treatment in Onychomycosis     1/22/2008
Watson Pharmaceuticals, Inc. (WPI) Announces Preliminary Results From Phase III Onychomycosis Trials; Second Trial Failed To Demonstrate A Statistically Significant Greater Number Of Complete Cures As Compared To Placebo     12/11/2003

News from Around the Web
No News Posted on that date

Press Releases
Viamet Reports Positive Results From Interim Analysis Of RENOVATE Phase IIb Trial Of VT-1161 In Onychomycosis     3/2/2016
Valeant Pharmaceuticals International (VRX) Announces Approval of Jublia® for the Treatment of Onychomycosis in Canada     10/3/2013
Topica Pharmaceuticals Presents Interim Safety and Mycologic Results From Its Phase 2b/3 Onychomycosis Trial of 10% Luliconazole Solution at the Interscience Conference on Antimicrobial Agents and Chemotherapy     9/11/2013
Topica Pharmaceuticals Presents Findings From Phase 1/2 Trial of Luliconazole Solution, 10% in Onychomycosis at ICAAC 2012     9/14/2012
Topica Pharmaceuticals Initiates Phase 2b/3 Study of Luliconazole in Patients With Onychomycosis of the Toenails     6/27/2012
Anacor Pharmaceuticals, Inc. Completes Enrollment in Second of Two Phase 3 Trials of Tavaborole for Onychomycosis     12/28/2011
Topica Pharmaceuticals Announces Positive Results From Phase 1/2a Trial of Luliconazole for Treatment of Onychomycosis     6/20/2011
Moberg Derma Reports Positive Clinical Results for Emtrix     2/2/2011
Topica Pharmaceuticals Announces Enrollment of First Patient in Phase 1/2a Trial of Luliconazole for Treating Onychomycosis     1/11/2011
NB Therapeutics Completes Enrollment in Phase 2 Onychomycosis Study     1/6/2011
Anacor Pharmaceuticals, Inc. Announces First Patient Dosed in a Phase 3 Trial of AN2690 For Onychomycosis     12/16/2010
Moberg Derma Signs Distribution Agreement with Perrigo Company (PRGO)     8/16/2010
Celtic Pharma Announces Initiation of Phase III Trial of TDT 067 for the Treatment of Onychomycosis     4/30/2010
MacroChem Corporation (MCHM) Announces Phase 2 Data for EcoNail(R) in the Treatment of Onychomycosis     7/24/2008
Moberg Derma Patient Recruitment Finalized to Moberg Derma‚Äôs Clinical Phase III Trial for its K101 Product Candidate to Treat Nail Fungus     2/22/2008

//-->